908 Devices (MASS) Projected to Post Quarterly Earnings on Tuesday

908 Devices (NASDAQ:MASSGet Free Report) is anticipated to release its earnings data before the market opens on Tuesday, March 4th. Analysts expect 908 Devices to post earnings of ($0.35) per share and revenue of $17.05 million for the quarter.

908 Devices Price Performance

MASS opened at $2.24 on Friday. The company has a market capitalization of $78.00 million, a price-to-earnings ratio of -1.27 and a beta of 0.99. The firm’s fifty day moving average price is $2.42 and its two-hundred day moving average price is $2.97. 908 Devices has a 1 year low of $1.81 and a 1 year high of $7.91.

Analyst Ratings Changes

A number of research firms have issued reports on MASS. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Stifel Nicolaus lowered their target price on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of 908 Devices in a research note on Wednesday, February 19th. Leerink Partners reiterated a “market perform” rating and set a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Finally, Stephens reiterated an “overweight” rating and set a $6.00 target price on shares of 908 Devices in a research note on Wednesday, January 15th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $5.33.

View Our Latest Research Report on 908 Devices

About 908 Devices

(Get Free Report)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

Featured Stories

Earnings History for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.